News

25 Oct 2012
Cellectis extends its TAL technology intellectual property portfolio through the acquisition of two exclusive licenses from Iowa State University
Paris, France, October 25th, 2012 - Cellectis (Alternext: ALCLS), the genome engineering specialist, announces that it has signed two exclusive license agreements with the Iowa...
23 Oct 2012
Cellectis bioresearch Inc. wins a $6.9 million contract with The National Institutes of Health on iPS cells
Cambridge, Massachusetts (United States) October 23th 2012 - Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS...
16 Oct 2012
The National Institutes of Health awarded a contract to Cellectis bioresearch Inc.
Cambridge, Massachusetts (United States) October 16th 2012 - Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS...
Copyright 2012 Cellectis
Design & Development by EtonDigital